Who owns BioMarin Pharmaceutical?

Key details on BioMarin Pharmaceutical (Ticker: BMRN)

Who owns BioMarin Pharmaceutical?

Is BMRN a good stock to own? Find out who bought BioMarin Pharmaceutical, who sold BioMarin Pharmaceutical (BMRN) stock, and who holds a large position in BioMarin Pharmaceutical.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 38.66M $38.27M March 31, 2015
Capital Research Global Investors^ 17.99M $1.88B Dec. 31, 2015
FMR 14.61M $1.53B Dec. 31, 2015
Sands Capital Management 11.64M $1.22B Dec. 31, 2015
Vanguard 11.20M $1.17B Dec. 31, 2015
Jennison Associates 8.75M $721.69M March 31, 2016
T. Rowe Price Associates 8.03M $840.89M Dec. 31, 2015
PRIMECAP Management Company 7.33M $767.96M Dec. 31, 2015
Columbia Wanger Asset Management 5.67M $279.40M Dec. 31, 2012
JPMORGAN CHASE & CO 5.63M $612.05M Dec. 31, 2015
Sabby Management 5.00M $6500 Dec. 31, 2015
WINSLOW CAPITAL MANAGEMENT INC /MN 4.82M $328.84M March 31, 2014
Baker Bros. Advisors 4.12M $431.10M Dec. 31, 2015
Altrinsic Global Advisors 4.11M $141.20M Dec. 31, 2011
Wells Fargo & Company 4.08M $161.13M June 30, 2012
Inves 3.96M $156.73M June 30, 2012
STATE STREET CORPORATION 3.96M $285.63M Sept. 30, 2014

Who sold BioMarin Pharmaceutical?

Fund Name Date Sold Number of Shares Sold Share Valuation
Sectoral Asset Management June 30, 2011 4.79M $130.30M
Cramer Rosenthal McGlynn June 30, 2011 4.54M $123.60M
Munder Capital Management Dec. 31, 2010 3.95M $105.90M